Indian Pharma Network
For Urgent Support
24/7 Free Support
Call US
+91 9891296838 / 9811747774
Herclon (Trastuzumab) Injection. Available In India.
Herclon is indicated for the treatment of patients with HER2 positive advanced adenocarcinoma of the stomach or gastro-oesophageal junction. Brand Herclon (Trastuzumab) Injection Can be imported and made available on "Patient Name basis" treatment in India. If you have questions, please email IPN Support Team or Call Indian Pharma Network on +91 9891296838 (Mr. Tarun) / 9811747774 (Mr. Neeraj) for further details.
Herclon (trastuzumab) is used for the treatment of patients with breast and stomach cancer.
Herclon is indicated for the treatment of patients with metastatic breast cancer and Early breast cancer.
Herclon is indicated in combination with cisplatin and either capecitabine or 5-FU for the treatment of patients with HER2 positive advanced adenocarcinoma of the stomach or gastro-oesophageal junction who have not received prior anti-cancer treatment for their metastatic disease.
Herclon (trastuzumab) suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of Herclon (trastuzumab) brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the Lynparza (olaparib) tablets cost price in India.
The order for Herclon (trastuzumab) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer. It is specifically used for cancer that is HER2 receptor positive. It may be used by itself or together with other chemotherapy medication.
Trastuzumab was approved for medical use in the United States in September 1998, and in the European Union in August 2000. It is on the World Health Organization's List of Essential Medicines. A biosimilar was approved in the European Union in November 2017, and in the United States in December 2018.
Trasmab™ By Aureate Healthcare.
Herceptin By Genentech
Hertraz By Mylan
Eleftha By Intas
Can Mab By Biocon
Vivitra By Zydus
Herclon By Roche
Trasturel By Reliance
Biceltis By Emucure
Active Ingredients: Trastuzumab (Generic name)
Herclon 150 mg single-dose vials: each pack contains one vial of Herclon (150 mg trastuzumab).
Herclon 440 mg multi-dose vials: each pack contains one vial of Herclon (440 mg trastuzumab) and one 20 mL vial of Bacteriostatic Water for Injection.
Get In Touch
Indian Pharma Network
60/4 1st Floor, T&T Building, Indian Oil Complex,
Yusuf Sarai, New Delhi, Delhi 110016
Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398
Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in
Herclon (trastuzumab) suppliers in India
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Herclon (trastuzumab) on prescription and Import License in Patient's Name only.
For overseas patients, Herclon (trastuzumab) can be made available in Send your enquiry to find Herclon (trastuzumab) in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
News / Update for Herclon (trastuzumab).
For Herclon (trastuzumab) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
US FDA panel nod for Biocon breast cancer biosimilar For More Details
Global Herceptin (Trastuzumab) Biosimilar Clinical Trial Insight 2016: One of Roche's Three Her2+ Breast Cancer Drugs, Recorded a 15% Sales Increase in the US and a 10% Rise Overall - Research and Markets
ReadMore
